no edit summary
Line 120: Line 120:  
The IVSA conference this year was held at Glasgow and Edinburgh universities over the New Year period. Natalie Brown (RVC) presented WikiVet to the conference with a view to attracting more international student support for the project. Interest was shown in translating the wiki into other languages and in adding more content to widen the relevance beyond just the UK.  
 
The IVSA conference this year was held at Glasgow and Edinburgh universities over the New Year period. Natalie Brown (RVC) presented WikiVet to the conference with a view to attracting more international student support for the project. Interest was shown in translating the wiki into other languages and in adding more content to widen the relevance beyond just the UK.  
   −
'''28th November 2008 - WikiVet receives funding from the British Society of Toxicological Pathologists''' [[http://www.bstp.org.uk/ BSTP]]
+
[[News Archive]]
 
  −
The BSTP has just agreed to provide sponsorship to support the WikiVet project in 2009. This funding will be used to cover wiki server hosting costs at the University of London Computer Centre.
  −
 
  −
 
  −
'''23rd October 2008 - WikiDrugs Ready for Population'''
  −
 
  −
All the WikiClinical stub pages are now in place. Please feel free to start populating these pages with lots of clinical knowledge. If you are having trouble editing pages please refer back to our [[help:contents|help pages]].
  −
 
  −
 
  −
'''9th October 2008 - The Wiki is Launched'''[[Image: crew.jpg|right|thumb|150x|Attendees of the WikiVet Launch]]
  −
 
  −
The WikiVet project was officially launched at MEDEV, Newcastle University. People from varying aspects of the Veterinary, Educational, Pharmaceutical and Medical professions attended the conference. Five people also attended the virtual conference, which made for an exciting yet interactive session. We feel that the launch was a great success and look forward to watching WikiVet grow.
      
|}
 
|}
Line 144: Line 132:     
Adaptive immunity is a defense system built on specific cellular targeting. It takes time for the immune system to develop its weaponry (up to 96 hours after infection), but ultimately the adaptive response is far more effective because of its precision.
 
Adaptive immunity is a defense system built on specific cellular targeting. It takes time for the immune system to develop its weaponry (up to 96 hours after infection), but ultimately the adaptive response is far more effective because of its precision.
 +
 +
[[Image:BCR.jpg|thumb|right|150px|B-cell receptor binds two antigens in the ECF - B. Catchpole, RVC 2008]]
    
Once infection is identified, antigen is transported to lymphoid organs where it is recognised by naive B and T cells. Clonal expansion and differentiation of these cells occurs, and then the battle begins. The immune system can take several tacks, depending on the type of infection encountered. Ultimately, the goals of the adaptive response are two-fold: to produce neutralizing antibody, and to flag up infected cells for destruction. This annihilation can be carried out by the cells of both innate and adaptive immunity.
 
Once infection is identified, antigen is transported to lymphoid organs where it is recognised by naive B and T cells. Clonal expansion and differentiation of these cells occurs, and then the battle begins. The immune system can take several tacks, depending on the type of infection encountered. Ultimately, the goals of the adaptive response are two-fold: to produce neutralizing antibody, and to flag up infected cells for destruction. This annihilation can be carried out by the cells of both innate and adaptive immunity.
   −
[[Adaptive_Immunity_Flashcards_-_WikiBlood|Adaptive Immunity Flashcards]]
+
*[[Adaptive_Immune_System_-_WikiBlood|Adaptive Immunity - WikiBlood]]
 +
*[[Adaptive_Immunity_Flashcards_-_WikiBlood|Adaptive Immunity Flashcards]]
 
|}
 
|}
 
|-
 
|-